![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Ribozyme Pharmaceuticals, Inc. is based on a distinctive technology which uses antisense molecules that are also enzymes. An obvious use of these molecules is in the cleavage of mRNA for genes expressed in disease states or those encoded by infecting viruses. The Company has an impressive portfolio of patented ribozyme sequences relevant to a wide range of disorders, although questions remain over the degree of homology needed to target the enzyme and their stability and activity.
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
